Solicitation · Health

Research Funding Opportunities

www.als.org (opens in a new tab)Catalog updated

No deadline listed
Amount
$150,000
Program type
Solicitation
Field
Health
Eligible career stages
postdocs

About this program

The ALS Association's Hoffman ALS Clinical Trial Awards Program supports early- to mid-stage (phase 1 or 2a) biomarker-driven clinical trials of novel or repurposed ALS therapeutics (disease‑modifying or symptomatic) and imaging tracer development, providing up to $1,000,000 total funding over 2–3 years. Applicants must submit a letter of intent (LOI); only applicants invited after LOI review may submit full proposals, with invited full proposals due February 17, 2026, by 1:00 p.m. U.S. ET. Specific applicant eligibility is not listed in the posting beyond the LOI requirement, so prospective applicants should consult the ALS Association program guidelines for institution- and investigator-level criteria.

In FundFit

FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 50 or more similar programs in full.

Ask for a demo of this program The form opens already filled in.

Full eligibility

Source announcement

Similar programs